A critical discovery in cancer study is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This essential cancer protector protein is frequently disabled in many forms of malignancies, resulting https://kbookmarking.com/story21931322/nanobodies-restore-p53-new-potential-hope-for-malignant-treatment